Spencer E Brightman

Title: Spencer E Brightman: Innovator in Immune Response Modulation

Introduction

Spencer E Brightman is a notable inventor based in San Diego, CA, who has made significant contributions to the field of immunology. He holds a total of 3 patents that focus on enhancing human immune responses through innovative compounds and methods.

Latest Patents

One of his latest patents is titled "Use of toll-like receptor 2 (TLR-2) agonist for modulating human immune response." This patent provides Toll-like receptor 2 (TLR2) agonists that enhance human immune response and serve as adjuvants in vaccines. The TLR2 agonists include thiophenes, imidazoles, or phenyl-containing compounds, which may be compounds of various formulae and their pharmaceutically acceptable derivatives. These compounds are designed to treat and prevent diseases, including proliferative, inflammatory, autoimmune, infectious, or chronic diseases. Another significant patent is "Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response." This patent details imidazopyrimidine compounds that enhance human immune response and can be used as adjuvants in vaccines.

Career Highlights

Throughout his career, Spencer has worked with reputable organizations such as Children's Medical Center Corporation and Dana-Farber Cancer Institute. His work has focused on developing innovative solutions to improve immune responses, which are crucial in the fight against various diseases.

Collaborations

Spencer has collaborated with esteemed colleagues, including David J Dowling and Ofer Levy, to advance research in immunology and vaccine development.

Conclusion

Spencer E Brightman is a distinguished inventor whose work in immune response modulation has the potential to significantly impact medical science. His innovative patents and collaborations reflect his commitment to enhancing human health through scientific advancements.